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Conclusion This study reveals nearly 30% of the population are
under exposure with multiple risk factors with rising risk gradient
from rural to urban regions, presence of occult and overt altered
vascular biology indicating inﬂuence of environmental factors.
The data emphasizes the need for such studies in different regions
across the country to evolve strategic plan at population level for
early identiﬁcation and intervention to thwart untimely vascular
death.
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Background: Limited data are available to assesswhether access to
and quality of cardiovascular disease (CVD) care are comparable
among men and women in India. We analyzed data from the
American College of Cardiology's PINNACLE (Practice Innovation
and Clinical Excellence) India Quality Improvement Program
(PIQIP) to evaluate gender disparities in CVD care delivery.
Methods and results: Between 2011 and 2015, we collected data on
performance measures for patients with coronary artery disease
(CAD) (n = 14,010), heart failure (HF) (n = 11,965) and atrial ﬁbrilla-
tion (AF) (n = 496) in PIQIP, among 17 participating practices.
The total number of women was 5,301 (20.0% of the cohort). The
number of patient encounters were signiﬁcantly low for women
compared to men (2.59 vs. 2.82, p = <0.001). Women were signiﬁ-
cantly younger (48.9 years vs. 51.5 years, p = <0.001), but had a
higher co-morbidity burden compared to men – hypertension
(62.0% vs. 45.6%, p = <0.001), diabetes (39.4% vs. 35%, p = <0.001),
and hyperlipidemia (3.7% vs. 3.1%, p = 0.19). On the contrary, the
medication prescription rateswere strikingly lower inwomenwith
CAD compared to men – aspirin (38% vs. 50.4%, p = <0.001), aspirin
or thienopyridine combination (46.9% vs. 57.2%, p = <0.001), and
beta-blockers (36.8% vs. 47.8%, p = <0.001). Similarly, among
women with ejection fraction <40%, the use of guideline-directed
medical therapywas signiﬁcantly lower compared tomen for beta-
blockers (30.8% vs. 37.0%, p = <0.001), angiotensin-converting
enzyme inhibitors (ACE-i) or angiotensin receptor blockers (ARBs)
(29.3% vs. 34.9%, p = <0.001), and beta-blockers/ACE-i or ARBs
(24.6% vs. 31.0%, p = <0.001). Among patients with AH and CHADS2
score ≥2, more women were on oral anticoagulation (19.6% vs.
14.6%, p = 0.34), although this was not signiﬁcantly different
between men and women, and the overall number of patients
with AH was low.
Conclusions: Although documentation of guideline-directed med-
ical therapy was low for both genders, signiﬁcant gender dispa-
rities exist in CVD care access and delivery in India, with a
strikingly low percentage of women receiving guideline-directed
CVD medical therapy compared to men, despite a signiﬁcantly
higher co-morbidity burden. These ﬁndings should provide
impetus to identify potential causes for, and seek solutions to
narrow these disparities.
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Background: With the increase of cardiovascular risk factors in
India the prevalence of coronary heart disease is also expected to
rise. A cross sectional study in 2010–2012 assessed the prevalence
of coronary heart disease in Kaniyambadi, a rural block and urban
Vellore, Tamil Nadu and compared the current prevalencewith the
prevalence of coronary heart disease in the same areas in 1991–
1994.
Two cross sectional surveys were carried out to determine the
prevalence of coronary heart disease in a rural block in Vellore
district and in Vellore town in 1991–1994 and 2010–2012. The
numbers of participants were 7342 in 1991–1994 and 4845 in
2010–2012, aged 30–60 years. Coronary heart disease was deﬁned
as previously diagnosed, symptoms detected using Rose angina
questionnaire or ischemic changes on electrocardiography (ST, T
and Q wave changes, read by trained cardiologists).
The age adjusted prevalence in rural women nearly tripled and
urban women doubled, with only a slight increase among males,
between 1991–1994 and 2010–2012 in both urban and rural Vellore,
south India.
The large increase in prevalence rates of coronary heart disease
among women, suggests the need for further conﬁrmatory studies
and interventions for prevention, especially targeting women who
are generally considered to be at a lower risk for coronary heart
disease.
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Introduction: Coronary artery disease (CAD) is the leading cause of
morbidity and mortality in the present world. Risk factor assess-
ment, prevention and treatment of CAD is an important aspect of
present day research. CHADS2 and CHA2DS2-VASc scores have
been previously used for assessing prognostic risk of thromboem-
bolism in non valvular atrial ﬁbrillation patients. They include
similar risk factors for the development of CAD and may provide
crucial information regarding the severity of coronary artery
lesions. To increase the likelihood of determining CAD severity,
the CHA2DS2-VASc-HS and CHA2DS2-VASc-HSF score comprising
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